RecruitingNCT07571096

Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia


Sponsor

Guangdong Women and Children Hospital

Enrollment

100 participants

Start Date

Mar 4, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This observational case-control study aims to develop a multidimensional risk assessment model for thrombophilia-related abnormalities in females with polycystic ovary syndrome (PCOS). The study will analyze endocrine, metabolic, and genetic factors associated with decreased protein C and/or protein S levels in participants with PCOS. The results are expected to provide evidence for risk stratification and individualized management in this population.


Eligibility

Sex: FEMALEMin Age: 14 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with polycystic ovary syndrome (pcos) and thrombophilia. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 14 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Guangdong Women and Children Hospital

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07571096


Related Trials